ANDAORALTABLET
Approved
Apr 2021
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TIOPRONIN (tiopronin) by Teva is cystine disulfide reduction [moa]. Approved for reducing and complexing thiol [epc]. First approved in 2021.
Drug data last refreshed 19h ago
Mechanism of Action
Cystine Disulfide Reduction
Pharmacologic Class:
Reducing and Complexing Thiol
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Teva
Israel - Petach Tikva
Worked on TIOPRONIN at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.